Cogent Biosciences (COGT) Net Equity Issued and Repurchased (2017 - 2026)
Cogent Biosciences' Net Equity Issued and Repurchased was $2.96 million in Q2 2026, down 48.7% from the prior quarter.
Powered by 
Analysis
Cogent Biosciences (COGT) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cogent Biosciences' Net Equity Issued and Repurchased was $19.67 million through Jun 30, 2026; for FY2025, it was $11.55 million.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $916,000 in FY2024 (-5.1%), $965,000 in FY2023 (-22.1%), $1.24 million in FY2022 and $31,000 in FY2021 (-99.9%).
- Quarterly Net Equity Issued and Repurchased has moved between -$204.25 million (Q4 2025) and $215.21 million (Q3 2025) over five years.
- Per Business Quant data, COGT's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $5.76 million (Q1 2026), -$204.25 million (Q4 2025) and $215.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Cogent Biosciences | 5.49 Bn | 5.49 Bn | - | 2.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.96 Mn |
| Mar 31, 2026 | 5.76 Mn |
| Dec 31, 2025 | -204.25 Mn |
| Sep 30, 2025 | 215.21 Mn |
| Mar 31, 2025 | 584,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 561,000.00 |
| Mar 31, 2024 | 356,000.00 |
| Dec 31, 2023 | -160.85 Mn |
| Mar 31, 2023 | 313,000.00 |
| Dec 31, 2022 | 315,000.00 |
| Sep 30, 2022 | 794,000.00 |
| Mar 31, 2022 | 129,000.00 |
| Dec 31, 2020 | 14.33 Mn |
| Sep 30, 2020 | 10.57 Mn |
| Jun 30, 2020 | 62,000.00 |
| Mar 31, 2020 | 38,000.00 |
| Jun 30, 2019 | 97,000.00 |
| Mar 31, 2019 | 11,000.00 |
| Jun 30, 2018 | 66.77 Mn |
API Access
Cogent Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=COGT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "COGT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=COGT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();